Follow-up notice: Urine drug rapid test procurement
About This Opportunity
TranslatedProcurement of urine drug rapid tests, including those with manipulation parameters and for alpha-PVP.
This is a supplies contract in the governance and public administration sector. Located in Finland, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 580,000.
Published through Hilma Finland, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from fiFimlab Laboratoriot Oy is tendering for its operational area's point-of-care and rapid analytics needs.
Screening tests (visual reading):
Drug test, urine, incl. manipulation parameters
Drug test, urine, incl. alfa-PVP
The product to be procured must be a point-of-care testing device intended for professional use in accordance with the IVD Regulation (in accordance with the transition periods of Regulation 2017/746) and must meet the requirements of national legislation. The products must bear the CE marking.
The tender concerns operations supported by Fimlab's point-of-care analytics services in the wellbeing services counties of Kanta-Häme, Central Finland, Pirkanmaa, Ostrobothnia, and Päijät-Häme. Distribution of screening tests to healthcare units will be carried out through the wellbeing services counties' logistics operators or as Fimlab's own purchase. The distributors are Nova Pharmacy of the Central Finland Wellbeing Services County, the warehouse operator of the Päijät-Häme Wellbeing Services County, Tuomi Logistiikka (Tampere), and the warehouse of the Ostrobothnia Wellbeing Services County (Vaasa, Närpiö, and Pietarsaari).
The distributors' volumes have been taken into account in the total volumes of the procurement. The consumption quantities of the products to be procured are based on previous one-year consumption data or an estimate of future consumption. Actual consumption may differ from previous consumptions or estimates. The estimate of the procurement quantity for the contract period does not bind the Customer.
The procurement is divided into 2 lots. One (1) Supplier will be selected for each lot. This is a contract between Fimlab Laboratoriot Oy and one supplier (per lot). The contract period is four years, after which it can be extended indefinitely. The estimated start date of the contract is 1.3.2026., 1.Drug test, urine, incl. manipulation parameters Fimlab Laboratoriot Oy is tendering for its operational area's point-of-care and rapid analytics needs.
Screening tests (visual reading):
Drug test, urine, incl. manipulation parameters
The product to be procured must be a point-of-care testing device intended for professional use in accordance with the IVD Regulation (in accordance with the transition periods of Regulation 2017/746) and must meet the requirements of national legislation. The products must bear the CE marking.
The tender concerns operations supported by Fimlab's point-of-care analytics services in the wellbeing services counties of Kanta-Häme, Central Finland, Pirkanmaa, Ostrobothnia, and Päijät-Häme. Distribution of screening tests to healthcare units will be carried out through the wellbeing services counties' logistics operators or as Fimlab's own purchase. The distributors are Nova Pharmacy of the Central Finland Wellbeing Services County, the warehouse operator of the Päijät-Häme Wellbeing Services County, Tuomi Logistiikka (Tampere), and the warehouse of the Ostrobothnia Wellbeing Services County (Vaasa, Närpiö, and Pietarsaari).
The distributors' volumes have been taken into account in the total volumes of the procurement. The consumption quantities of the products to be procured are based on previous one-year consumption data or an estimate of future consumption. Actual consumption may differ from previous consumptions or estimates. The estimate of the procurement quantity for the contract period does not bind the Customer.
The procurement is divided into 2 lots. One (1) Supplier will be selected for each lot. This is a contract between Fimlab Laboratoriot Oy and one supplier (per lot). The contract period is four years, after which it can be extended indefinitely., 2. Drug test, urine, incl. alfa-PVP Fimlab Laboratoriot Oy is tendering for its operational area's point-of-care and rapid analytics needs.
Screening tests (visual reading):
Drug test, urine, incl. alfa-PVP
The product to be procured must be a point-of-care testing device intended for professional use in accordance with the IVD Regulation (in accordance with the transition periods of Regulation 2017/746) and must meet the requirements of national legislation. The products must bear the CE marking.
The tender concerns operations supported by Fimlab's point-of-care analytics services in the wellbeing services counties of Kanta-Häme, Central Finland, Pirkanmaa, Ostrobothnia, and Päijät-Häme. Distribution of screening tests to healthcare units will be carried out through the wellbeing services counties' logistics operators or as Fimlab's own purchase. The distributors are Nova Pharmacy of the Central Finland Wellbeing Services County, the warehouse operator of the Päijät-Häme Wellbeing Services County, Tuomi Logistiikka (Tampere), and the warehouse of the Ostrobothnia Wellbeing Services County (Vaasa, Närpiö, and Pietarsaari).
The distributors' volumes have been taken into account in the total volumes of the procurement. The consumption quantities of the products to be procured are based on previous one-year consumption data or an estimate of future consumption. Actual consumption may differ from previous consumptions or estimates. The estimate of the procurement quantity for the contract period does not bind the Customer.
The procurement is divided into 2 lots. One (1) Supplier will be selected for each lot. This is a contract between Fimlab Laboratoriot Oy and one supplier (per lot). The contract period is four years, after which it can be extended indefinitely.,
Lot 1: 1.Drug test, urine, incl. manipulation parameters
Fimlab Laboratoriot Oy is tendering for its operational area's point-of-care and rapid analytics needs.
Screening tests (visual reading):
Drug test, urine, incl. manipulation parameters
The product to be procured must be a point-of-care testing device intended for professional use in accordance with the IVD Regulation (in accordance with the transition periods of Regulation 2017/746) and must meet the requirements of national legislation. The products must bear the CE marking.
The tender concerns operations supported by Fimlab's point-of-care analytics services in the wellbeing services counties of Kanta-Häme, Central Finland, Pirkanmaa, Ostrobothnia, and Päijät-Häme. Distribution of screening tests to healthcare units will be carried out through the wellbeing services counties' logistics operators or as Fimlab's own purchase. The distributors are Nova Pharmacy of the Central Finland Wellbeing Services County, the warehouse operator of the Päijät-Häme Wellbeing Services County, Tuomi Logistiikka (Tampere), and the warehouse of the Ostrobothnia Wellbeing Services County (Vaasa, Närpiö, and Pietarsaari).
Distributors' vol...
Data provenance
This notice is sourced from Hilma Finland and was originally published on May 12, 2026. Last refreshed 34 days ago. Original language: fi. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Fimlab Laboratoriot Oy
Fimlab Laboratoriot Oy has issued 28 procurement notices on BidsFactory, including 5 currently open and 10 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Finland. Notices are distributed via Hilma Finland and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Is this tender still open?
No — the contract has already been awarded to OneMed Oy (1558201-5). The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Fimlab Laboratoriot Oy in Finland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Governance & Public Administration sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €580,000. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Finland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Hilma Finland to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Key Details
Source
Contracting Authority
Companies That Won Similar
Companies with awards in Governance & Public Administration in Finland